No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
A Quick Look at Today's Ratings for Tenaya Therapeutics(TNYA.US), With a Forecast Between $6 to $19
Tenaya Therapeutics Is Maintained at Buy by Chardan Capital
Tenaya Therapeutics Analyst Ratings
Cautious Optimism for Tenaya Therapeutics' TN-201: Early Phase Study Shows Promising Efficacy and Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Update: Tenaya Shares Sink After Readout of Heart Disease Therapy Shows Manageable Safety Profile